STOCK TITAN

SciSparc (SPRC) shareholders back all proposals at August 26 meeting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

SciSparc Ltd. reports that its shareholders approved all proposals presented at an adjourned special general meeting held on August 26, 2025. The proposals were approved by the required majority under Israeli Companies Law and the company’s amended and restated articles of association, as described in the proxy statement/prospectus sent to shareholders.

The company also states that this report is incorporated by reference into several of its existing registration statements on Form F-3 and Form S-8, meaning those registration statements now include this update as part of their disclosed information.

Positive

  • None.

Negative

  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of August 2025 (Report No. 3)

 

Commission file number: 001- 38041

 

SCISPARC LTD.

(Translation of registrant’s name into English)

 

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F        Form 40-F 

 

 

 

 

 

 

CONTENTS

 

SciSparc Ltd. (the “Company”) hereby announces that the shareholders of the Company approved all of the proposals brought before the adjourned special general meeting of shareholders held on August 26, 2025 (the “Meeting”), by the respective requisite majority in accordance with the Israeli Companies Law, 5759-1999, and the Company’s amended and restated articles of association, as described in the proxy statement/prospectus, filed with the Securities and Exchange Commission (the “SEC”) on July 21, 2025, and sent to shareholders in connection with the Meeting.

 

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-286099333-275305333-269839333-266047333-248670 and 333-255408) and on Form S-8 (File Nos. 333-278437333-225773 and 333-286791) filed with the SEC to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. 

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SciSparc Ltd.
   
Date: August 26, 2025 By:  /s/ Oz Adler
    Name:  Oz Adler
    Title: Chief Executive Officer

 

 

2

 

 

FAQ

What did SciSparc Ltd. (SPRC) announce in this Form 6-K?

SciSparc Ltd. announced that shareholders approved all proposals presented at an adjourned special general meeting held on August 26, 2025, by the requisite majority under Israeli law and the company’s articles.

When was SciSparc Ltd.'s special general meeting held?

The adjourned special general meeting of SciSparc Ltd. shareholders was held on August 26, 2025.

Were all SciSparc Ltd. proposals approved at the August 26, 2025 meeting?

Yes. SciSparc Ltd. states that all proposals brought before the adjourned special general meeting on August 26, 2025 were approved by the required majority.

Where were the details of SciSparc Ltd.’s proposals described?

The proposals were described in a proxy statement/prospectus filed with the SEC on July 21, 2025 and sent to SciSparc Ltd. shareholders in connection with the meeting.

How does this 6-K affect SciSparc Ltd.’s existing registration statements?

SciSparc Ltd. states that this 6-K is incorporated by reference into its registration statements on Form F-3 and Form S-8, making this information part of those filings from the submission date.

Who signed SciSparc Ltd.’s August 2025 Form 6-K?

The Form 6-K was signed on behalf of SciSparc Ltd. by Oz Adler, the company’s Chief Executive Officer.
Scisparc

NASDAQ:SPRC

View SPRC Stock Overview

SPRC Rankings

SPRC Latest News

SPRC Latest SEC Filings

SPRC Stock Data

2.26M
517.11k
Biotechnology
Healthcare
Link
Israel
Tel Aviv-Yafo